This biopharma innovator in rare disease therapies reported a notable insider sale amid a year of strong stock performance.

Prominent biotech Biogen ( BIIB +5.94%) loomed large on the stock market on Wednesday. It published its latest set of ...

Starting at the individual level first, the leading cryptocurrency's evolution hasn't been like typical financial assets.

You may be thinking, "Nvidia is already the largest company in the world, how much more upside could it even have from here?" ...

Poet Technologies (POET 17.81%) stock got hit with another round of crushing sell-offs in Wednesday's trading. The company's ...

Seagate expects revenue of roughly $3.45 billion and adjusted earnings per share of $5.00 in its fiscal fourth quarter. Both ...

Wednesday, April 29, 2026 at 5 p.m. ET. CALL PARTICIPANTS. Chief Executive Officer and President — Ajay Amlani; Chief ...

Could InterDigital be your next big investment? Tune in as our experts break down its strengths, management, financials, and valuation to help you decide if this stock is worth your attention.

I will start by walking through the key drivers of our Q1 results and then cover our Q2 outlook. As Steve mentioned, ...

Markets were relatively flat today as investors awaited megacap earnings and Federal Reserve Chair Jerome Powell’s comments ...

KalVista Pharmaceuticals’ stock is pricing in a high likelihood that the company will be taken private by Italy’s Chiesi ...

Agios Pharmaceuticals (AGIO +13.11%) was a standout stock in the healthcare sector on Hump Day. Investors eagerly snapped up ...